Download presentation
Presentation is loading. Please wait.
Published byNora Preston Modified over 6 years ago
1
Companies Researching Cancer Treatments By: Amanda Garcia
Company Investment Companies Researching Cancer Treatments By: Amanda Garcia
2
Applera Acquired by Life Technologies brand under the Thermo Fisher Scientific Corporation in 2006 Thermo Fisher and its brands specialize in laboratory equipment/technology 52-week stock of TFS: High and Low Known partnerships: Seegene, Megaware, Symyx Technologies Inc, and Arkivum
3
Onyx Pharmaceuticals Biopharmaceutical company that marketed and developed medicines for cancer treatment Acquired by Amgen in 2013 Amgen currently has 33 pre-clinical and clinical targets in various phases; specialize in various illnesses like cancer 52-week stock: High and Low Known partnerships: Novartis, Daiichi, Immatics, SiteOne and many others worldwide
4
United Therapeutics Biotechnology company that specializes in development and commercialization of chronic and life-threatening conditions In 2015, FDA approved a new drug that will treat neuroblastoma, a rare cancer found in children 52-week stock: High and Low Known partnerships: Northwell Health and Memorial Sloan- Kettering Cancer Center
5
Crucell NV Now a subsidiary of Janssen Pharmaceutical Companies of Johnson & Johnson since 2011 Crucell had specialized in vaccines for infectious diseases Janssen researches and develops treatments in many fields, including oncology 52-week stock: High and Low Have over 400 partnerships worldwide
6
Mankind Corporation Biopharmaceutical company that focuses on therapeutic products for diseases, such as diabetes Have 1 FDA approved insulin drug called “Afrezza” Developing 3 other medications for clinical trials 52-week stock: High and Low- 0.67 Known partnerships: Juvenile Diabetes Research Foundation, The Leukemia and Lymphoma Society, OneDrop Foundation
7
Conclusion Most optimal companies to invest in: Janssen Pharmaceuticals and Amgen Both have well-established roots and steady growth Have had consistent development in cancer research Are multinational, with plenty of funding and access to many variables for clinical trials
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.